Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

In vitro permeation and in vivo anti-inflammatory and analgesic properties of nanoscaled emulsions containing ibuprofen for topical delivery.

Abdullah GZ, Abdulkarim MF, Salman IM, Ameer OZ, Yam MF, Mutee AF, Chitneni M, Mahdi ES, Basri M, Sattar MA, Noor AM.

Int J Nanomedicine. 2011;6:387-96. doi: 10.2147/IJN.S14667. Epub 2011 Feb 17.

2.

Carbopol 934, 940 and Ultrez 10 as viscosity modifiers of palm olein esters based nano-scaled emulsion containing ibuprofen.

Abdullah GZ, Abdulkarim MF, Mallikarjun C, Mahdi ES, Basri M, Sattar MA, Noor AM.

Pak J Pharm Sci. 2013 Jan;26(1):75-83.

PMID:
23261730
3.

Topical piroxicam in vitro release and in vivo anti-inflammatory and analgesic effects from palm oil esters-based nanocream.

Abdulkarim MF, Abdullah GZ, Chitneni M, Salman IM, Ameer OZ, Yam MF, Mahdi ES, Sattar MA, Basri M, Noor AM.

Int J Nanomedicine. 2010 Nov 4;5:915-24. doi: 10.2147/IJN.S13305.

4.

Mechanical properties, skin permeation and in vivo evaluations of dexibuprofen-loaded emulsion gel for topical delivery.

Jin SG, Yousaf AM, Son MW, Jang SW, Kim DW, Kim JO, Yong CS, Kim JH, Choi HG.

Arch Pharm Res. 2015 Feb;38(2):216-22. doi: 10.1007/s12272-014-0367-8. Epub 2014 Mar 24.

PMID:
24988989
5.

Modification of palm kernel oil esters nanoemulsions with hydrocolloid gum for enhanced topical delivery of ibuprofen.

Salim N, Basri M, Rahman MB, Abdullah DK, Basri H.

Int J Nanomedicine. 2012;7:4739-47. doi: 10.2147/IJN.S34700. Epub 2012 Sep 7.

6.

Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.

Djekic L, Primorac M, Filipic S, Agbaba D.

Int J Pharm. 2012 Aug 20;433(1-2):25-33. doi: 10.1016/j.ijpharm.2012.04.070. Epub 2012 May 3.

PMID:
22579578
7.

Design of Block Copolymer Costabilized Nonionic Microemulsions and Their In Vitro and In Vivo Assessment as Carriers for Sustained Regional Delivery of Ibuprofen via Topical Administration.

Djekic L, Martinovic M, Stepanović-Petrović R, Tomić M, Micov A, Primorac M.

J Pharm Sci. 2015 Aug;104(8):2501-12. doi: 10.1002/jps.24494. Epub 2015 Jun 4.

PMID:
26045240
8.

Development of ibuprofen nanoliposome for transdermal delivery: Physical characterization, in vitro/in vivo studies, and anti-inflammatory activity.

Gaur PK, Bajpai M, Mishra S, Verma A.

Artif Cells Nanomed Biotechnol. 2016;44(1):370-5. doi: 10.3109/21691401.2014.953631. Epub 2014 Sep 11.

PMID:
25211229
9.

Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.

Hussain A, Samad A, Singh SK, Ahsan MN, Haque MW, Faruk A, Ahmed FJ.

Drug Deliv. 2016;23(2):642-47. doi: 10.3109/10717544.2014.933284. Epub 2014 Jul 11.

PMID:
25013957
10.

[Comparative in vitro and in vivo studies on the permeation and penetration of ketoprofen and ibuprofen in human skin].

Bock U, Krause W, Otto J, Haltner E.

Arzneimittelforschung. 2004;54(9):522-9. German.

PMID:
15500198
11.

Anti-inflammatory and analgesic effects of ketoprofen in palm oil esters nanoemulsion.

Sakeena MH, Yam MF, Elrashid SM, Munavvar AS, Azmin MN.

J Oleo Sci. 2010;59(12):667-71.

12.

In vitro, ex vivo, and in vivo evaluation of the effect of saturated fat acid chain length on the transdermal behavior of ibuprofen-loaded microemulsions.

Ren Q, Deng C, Meng L, Chen Y, Chen L, Sha X, Fang X.

J Pharm Sci. 2014 Jun;103(6):1680-91. doi: 10.1002/jps.23958. Epub 2014 Apr 3.

PMID:
24700251
13.

Optimization of skin permeation and distribution of ibuprofen by using nanostructures (coagels) based on alkyl vitamin C derivatives.

Saino V, Monti D, Burgalassi S, Tampucci S, Palma S, Allemandi D, Chetoni P.

Eur J Pharm Biopharm. 2010 Nov;76(3):443-9. doi: 10.1016/j.ejpb.2010.08.004. Epub 2010 Sep 9.

PMID:
20832470
14.

Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.

Han F, Yin R, Che X, Yuan J, Cui Y, Yin H, Li S.

Int J Pharm. 2012 Dec 15;439(1-2):349-57. doi: 10.1016/j.ijpharm.2012.08.040. Epub 2012 Sep 15.

PMID:
22989987
15.

The role of menthol in skin penetration from topical formulations of ibuprofen 5% in vivo.

Brain KR, Green DM, Dykes PJ, Marks R, Bola TS.

Skin Pharmacol Physiol. 2006;19(1):17-21. Epub 2005 Oct 20.

PMID:
16247245
16.

Microemulsion-based hydrogel formulation of ibuprofen for topical delivery.

Chen H, Chang X, Du D, Li J, Xu H, Yang X.

Int J Pharm. 2006 Jun 6;315(1-2):52-8. Epub 2006 Apr 5.

PMID:
16600540
17.

Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia).

Ali J, Akhtar N, Sultana Y, Baboota S, Ahuja A.

Methods Find Exp Clin Pharmacol. 2008 May;30(4):277-85. doi: 10.1358/mf.2008.30.4.1185802.

PMID:
18773122
18.

Optimizing surfactant content to improve oral bioavailability of ibuprofen in microemulsions: just enough or more than enough?

You X, Xing Q, Tuo J, Song W, Zeng Y, Hu H.

Int J Pharm. 2014 Aug 25;471(1-2):276-84. doi: 10.1016/j.ijpharm.2014.05.031. Epub 2014 May 22.

PMID:
24858390
19.

Formulation of hydrogel-thickened nonionic microemulsions with enhanced percutaneous delivery of ibuprofen assessed in vivo in rats.

Djekic L, Martinovic M, Stepanović-Petrović R, Micov A, Tomić M, Primorac M.

Eur J Pharm Sci. 2016 Sep 20;92:255-65. doi: 10.1016/j.ejps.2016.05.005. Epub 2016 May 6.

PMID:
27157041
20.

Development of a new nanovesicle formulation as transdermal carrier: formulation, physicochemical characterization, permeation studies and anti-inflammatory activity.

Gaur PK, Mishra S, Purohit S, Kumar Y, Bhandari A.

Artif Cells Nanomed Biotechnol. 2014 Oct;42(5):323-30. doi: 10.3109/21691401.2013.827119. Epub 2013 Aug 15.

PMID:
23944163

Supplemental Content

Support Center